Skip to main content
Screener/Healthcare/Biotechnology

FULC Fulcrum Therapeutics, Inc.

NASDAQ
$3.15-3.29 (-51.17%)
$5.89
$15.74
$2.83
$3.26
EPS (TTM)$-1.15
P/E Ratio-7.45
Dividend Yield
Market Cap$374.5M
Volume24.18M
Prev Close$6.42
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$18.9M$-0.25
Q4 '25$0-$20.3M$-0.31
Q3 '25$0-$19.6M$-0.31
Q2 '25$0-$17.3M$-0.28
Q1 '25$0-$17.7M$-0.28
Q4 '24$0-$16.6M$-0.31
Q3 '24$0-$21.7M$-0.35
Q2 '24$80.0M$55.4M$0.8778.4%69.3%
Get Your Daily Market Recap